Many thanks to all of you for the great teamwork!

People living with #HeartFailure (HF) with preserved ejection fraction (HFpEF) have worse muscle function and predominant muscle atrophy compared with those with HF with reduced ejection fraction (#HFrEF) buff.ly/38aLkY6 | Circ Heart Fail #WorseningHeartFailure

New publication from our group at UKJ. Outpatients with HFpEF had worse quality of life and higher anxiety and depression scores compared with HFrEF patients. Depression is an independent predictor for reduced coordination capacity. doi.org/10.1002/ehf2.1… @PCSchulzeMD

Have a look at this #ESCAbstract on the #ESCCongress Research Gateway cyim.page.link/bn2r via European Society of Cardiology

Have a look at this #ESCAbstract on the #ESCCongress Research Gateway cyim.page.link/dXTV via European Society of Cardiology

Meeting Syrian friends #HeartFailure2022 in Madrid Asim Katbeh. MD. PhD. FESC Amr Abdin SyGAAD # reunion

#CallForPapers "Non-Cardiac Comorbidities of Heart Failure Through the Spectrum of Ejection Fraction" 📅 18th November 2022 Submit your paper here 👉 fro.ntiers.in/MB9b

I am very happy and excited to start next week a master’s degree in clinical trials in Cardiovascular Medicine at #Oxford University. Many thanks to all my mentors for all the support. Many thanks for the generous grant from the #European Society of Cardiology (#esc).

Wonderful group of people, all here with one primary goal #MScinClinicalTrials European Society of Cardiology Oxford Population Health (OxPop) Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA Ahmed Teebi, MD MPH🗝️ Waseem Raja Dharmaraj Karthikesan MD FRCP MSc Mihaela Roxana Popescu Kris G. Vargas

🌟This morning University of Oxford 🇬🇧 with this terrific group of Cardiologists & future #Trialists from 20+ countries! 🇺🇸🇮🇪🇳🇴🇦🇺🇵🇸🇲🇾🇩🇪🇿🇦🇨🇭🇬🇧 Meet our MSc in Clinical Trials class #Oxford from USA, UK, Denmark, Ireland, Germany, Switzerland, Romania, Palestine, Malaysia, Australia, and

The last supper - what an amazing group of people. Cannot wait to see you again in March when we will be presenting our trial proposals ❤️! European Society of Cardiology Oxford Population Health (OxPop) Ahmed Teebi, MD MPH🗝️ Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA Mihaela Roxana Popescu Kris G. Vargas Dharmaraj Karthikesan MD FRCP MSc Waseem Raja Felix Ehret Don’t trust the p-value!

What a week attending the residentials for the MSc in Clinical Trials Oxford Population Health (OxPop) University of Oxford I shudder to think what else this group might achieve together in future! European Society of Cardiology Manan Pareek, MD, MSc, PhD, FAHA, FESC Mihaela Roxana Popescu Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA Kris G. Vargas Ahmed Teebi, MD MPH🗝️ Waseem Raja Felix Ehret

Liebe Kolleginnen und Kollegen, an den großen Erfolg im letzten Jahr möchten wir anknüpfen und Sie/Euch herzlich zum 2. Mitteldeutschen Herzinsuffizienz-Symposium am 18. November 2023 ab 8.45 Uhr in das Gesellschaftshaus Magdeburg einladen. Wir freuen uns auf Ihr Kommen!

"In pts with AF on OAC who underwent PCI for MI, ticagrelor/prasugrel vs. clopidogrel was associated with reduced ischemic risk, without a concomitantly increased bleeding risk" - out now in European Society of Cardiology Journals #EHJOpen Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA Kristian Kragholm Dr. Deepak L. Bhatt academic.oup.com/ehjopen/advanc…

Yesterday, we received our final #MScinClinicalTrials grades from Oxford Population Health (OxPop). Today, our #CardioPulse paper on the program is out in European Society of Cardiology Journals! Led by Felix Ehret Tarek Bekfani, MD, (Priv.-Doz.), MSc, FESC, FHFA academic.oup.com/eurheartj/adva… Huge thanks to everyone involved in the program! Dr. Deepak L. Bhatt